Daniel Paul Dickstein, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 70 | 2023 | 5092 | 5.470 |
Why?
|
Irritable Mood | 11 | 2024 | 193 | 2.540 |
Why?
|
Self-Injurious Behavior | 8 | 2022 | 566 | 2.410 |
Why?
|
Suicide, Attempted | 11 | 2023 | 1402 | 1.970 |
Why?
|
Reversal Learning | 7 | 2016 | 57 | 1.900 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 24 | 2024 | 3707 | 1.820 |
Why?
|
Suicidal Ideation | 10 | 2022 | 1447 | 1.680 |
Why?
|
Facial Expression | 8 | 2015 | 507 | 1.470 |
Why?
|
Adolescent Behavior | 7 | 2022 | 1188 | 1.440 |
Why?
|
Emotions | 11 | 2022 | 2742 | 1.150 |
Why?
|
Mood Disorders | 11 | 2024 | 1124 | 1.130 |
Why?
|
Adolescent | 94 | 2024 | 88298 | 1.030 |
Why?
|
Anxiety Disorders | 14 | 2024 | 2723 | 0.980 |
Why?
|
Child Psychiatry | 3 | 2024 | 227 | 0.920 |
Why?
|
Executive Function | 9 | 2021 | 1388 | 0.910 |
Why?
|
Family Relations | 3 | 2018 | 317 | 0.900 |
Why?
|
Emotional Intelligence | 2 | 2015 | 135 | 0.900 |
Why?
|
Affective Symptoms | 3 | 2020 | 417 | 0.900 |
Why?
|
Child | 75 | 2023 | 80152 | 0.830 |
Why?
|
Rest | 3 | 2019 | 920 | 0.810 |
Why?
|
Guilt | 1 | 2022 | 95 | 0.760 |
Why?
|
Cognition | 9 | 2022 | 6988 | 0.710 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 7 | 2024 | 306 | 0.680 |
Why?
|
Caudate Nucleus | 4 | 2018 | 390 | 0.670 |
Why?
|
Frontal Lobe | 7 | 2018 | 1416 | 0.660 |
Why?
|
Brain Mapping | 11 | 2019 | 6635 | 0.660 |
Why?
|
Brain | 16 | 2022 | 27092 | 0.630 |
Why?
|
Face | 3 | 2015 | 1025 | 0.610 |
Why?
|
Risk-Taking | 2 | 2023 | 1038 | 0.610 |
Why?
|
Magnetic Resonance Imaging | 23 | 2023 | 36415 | 0.590 |
Why?
|
Temporal Lobe | 3 | 2012 | 1695 | 0.580 |
Why?
|
Cues | 1 | 2022 | 874 | 0.570 |
Why?
|
Child Abuse | 2 | 2022 | 1076 | 0.530 |
Why?
|
Depressive Disorder, Major | 6 | 2023 | 4767 | 0.520 |
Why?
|
Neuropsychological Tests | 17 | 2021 | 7046 | 0.500 |
Why?
|
Amygdala | 6 | 2014 | 1353 | 0.480 |
Why?
|
Age Factors | 12 | 2018 | 18384 | 0.480 |
Why?
|
Attention | 9 | 2020 | 2394 | 0.480 |
Why?
|
Maternal Age | 1 | 2017 | 809 | 0.450 |
Why?
|
Risperidone | 2 | 2016 | 381 | 0.450 |
Why?
|
Hypersensitivity, Immediate | 1 | 2016 | 348 | 0.440 |
Why?
|
Obsessive-Compulsive Disorder | 3 | 2020 | 1492 | 0.440 |
Why?
|
Diseases in Twins | 1 | 2015 | 446 | 0.430 |
Why?
|
Cognition Disorders | 5 | 2015 | 3976 | 0.430 |
Why?
|
Affect | 6 | 2020 | 1486 | 0.420 |
Why?
|
Humans | 115 | 2024 | 761208 | 0.410 |
Why?
|
Sleep Deprivation | 1 | 2019 | 847 | 0.390 |
Why?
|
Psychomotor Performance | 6 | 2015 | 1880 | 0.390 |
Why?
|
Child Development Disorders, Pervasive | 3 | 2013 | 600 | 0.390 |
Why?
|
Attitude to Death | 1 | 2015 | 400 | 0.390 |
Why?
|
Panic Disorder | 2 | 2014 | 613 | 0.390 |
Why?
|
Male | 82 | 2023 | 360693 | 0.380 |
Why?
|
Female | 80 | 2023 | 392544 | 0.370 |
Why?
|
Nerve Net | 2 | 2014 | 2288 | 0.370 |
Why?
|
Antipsychotic Agents | 3 | 2016 | 3064 | 0.370 |
Why?
|
Interpersonal Relations | 2 | 2015 | 1437 | 0.360 |
Why?
|
Comorbidity | 16 | 2019 | 10516 | 0.350 |
Why?
|
Social Problems | 1 | 2010 | 109 | 0.350 |
Why?
|
Personality Development | 1 | 2010 | 243 | 0.340 |
Why?
|
Age of Onset | 8 | 2023 | 3307 | 0.340 |
Why?
|
Behavior Therapy | 1 | 2015 | 875 | 0.330 |
Why?
|
Prefrontal Cortex | 9 | 2016 | 2219 | 0.320 |
Why?
|
Valproic Acid | 1 | 2012 | 443 | 0.320 |
Why?
|
Corpus Striatum | 3 | 2012 | 1234 | 0.320 |
Why?
|
Antimanic Agents | 3 | 2011 | 520 | 0.320 |
Why?
|
Social Control, Informal | 1 | 2009 | 44 | 0.320 |
Why?
|
Metformin | 1 | 2016 | 910 | 0.310 |
Why?
|
Mental Disorders | 7 | 2023 | 6823 | 0.310 |
Why?
|
Lithium Carbonate | 1 | 2009 | 179 | 0.300 |
Why?
|
Young Adult | 19 | 2023 | 59221 | 0.290 |
Why?
|
Adolescent Psychiatry | 1 | 2009 | 156 | 0.290 |
Why?
|
Drug Hypersensitivity | 1 | 2016 | 918 | 0.290 |
Why?
|
Parents | 2 | 2020 | 3564 | 0.280 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2018 | 2787 | 0.260 |
Why?
|
Cross-Sectional Studies | 11 | 2022 | 26071 | 0.260 |
Why?
|
Pattern Recognition, Visual | 1 | 2012 | 824 | 0.260 |
Why?
|
Social Perception | 5 | 2015 | 431 | 0.250 |
Why?
|
Periodicity | 1 | 2007 | 347 | 0.250 |
Why?
|
Visual Perception | 5 | 2015 | 1385 | 0.250 |
Why?
|
Social Adjustment | 2 | 2018 | 632 | 0.250 |
Why?
|
Cerebral Cortex | 2 | 2014 | 5775 | 0.250 |
Why?
|
Arousal | 2 | 2008 | 1171 | 0.240 |
Why?
|
Case-Control Studies | 11 | 2020 | 22174 | 0.230 |
Why?
|
Neural Pathways | 3 | 2010 | 3056 | 0.230 |
Why?
|
Memory | 3 | 2018 | 2190 | 0.230 |
Why?
|
Psychiatric Status Rating Scales | 15 | 2020 | 6011 | 0.220 |
Why?
|
Gyrus Cinguli | 4 | 2023 | 1114 | 0.210 |
Why?
|
Functional Laterality | 7 | 2010 | 2257 | 0.200 |
Why?
|
Editorial Policies | 2 | 2024 | 458 | 0.200 |
Why?
|
Neurologic Examination | 1 | 2005 | 915 | 0.200 |
Why?
|
Adolescent Development | 2 | 2016 | 282 | 0.200 |
Why?
|
Aging | 2 | 2018 | 8702 | 0.200 |
Why?
|
Adult | 25 | 2023 | 221119 | 0.200 |
Why?
|
Anticonvulsants | 1 | 2012 | 1910 | 0.190 |
Why?
|
Writing | 1 | 2023 | 199 | 0.190 |
Why?
|
Magnetic Resonance Spectroscopy | 3 | 2009 | 3770 | 0.190 |
Why?
|
Space Perception | 2 | 2005 | 465 | 0.190 |
Why?
|
Cholestasis, Intrahepatic | 1 | 2021 | 75 | 0.180 |
Why?
|
Longitudinal Studies | 10 | 2020 | 14610 | 0.180 |
Why?
|
Impulsive Behavior | 1 | 2022 | 346 | 0.170 |
Why?
|
Stress, Psychological | 1 | 2015 | 4487 | 0.170 |
Why?
|
Cost of Illness | 1 | 2009 | 1936 | 0.160 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2012 | 3366 | 0.160 |
Why?
|
Self Report | 3 | 2023 | 3727 | 0.160 |
Why?
|
Child Development | 3 | 2016 | 2302 | 0.160 |
Why?
|
Mother-Child Relations | 1 | 2022 | 495 | 0.160 |
Why?
|
Diffusion Tensor Imaging | 2 | 2020 | 2401 | 0.160 |
Why?
|
Phenotype | 5 | 2014 | 16575 | 0.160 |
Why?
|
Diagnosis, Differential | 7 | 2018 | 12976 | 0.150 |
Why?
|
Social Environment | 2 | 2017 | 1022 | 0.150 |
Why?
|
Trichotillomania | 1 | 2020 | 177 | 0.150 |
Why?
|
Peer Group | 1 | 2023 | 691 | 0.150 |
Why?
|
Inositol | 2 | 2009 | 215 | 0.150 |
Why?
|
Antigens, Dermatophagoides | 1 | 2017 | 98 | 0.140 |
Why?
|
Child Behavior | 3 | 2020 | 848 | 0.140 |
Why?
|
Depression | 6 | 2023 | 8132 | 0.140 |
Why?
|
Pyroglyphidae | 1 | 2017 | 89 | 0.140 |
Why?
|
Lipid Peroxides | 1 | 2016 | 74 | 0.140 |
Why?
|
Image Processing, Computer-Assisted | 5 | 2012 | 8998 | 0.140 |
Why?
|
Personality | 1 | 2020 | 553 | 0.140 |
Why?
|
Parenting | 1 | 2022 | 701 | 0.130 |
Why?
|
Prospective Studies | 7 | 2023 | 54435 | 0.130 |
Why?
|
Creatine | 2 | 2009 | 427 | 0.130 |
Why?
|
Aspartic Acid | 2 | 2009 | 574 | 0.130 |
Why?
|
Substance-Related Disorders | 3 | 2020 | 4413 | 0.130 |
Why?
|
Lipid Peroxidation | 1 | 2016 | 271 | 0.130 |
Why?
|
Aldehydes | 1 | 2016 | 170 | 0.130 |
Why?
|
Reference Values | 4 | 2015 | 4921 | 0.130 |
Why?
|
Principal Component Analysis | 1 | 2018 | 942 | 0.130 |
Why?
|
Postpartum Period | 1 | 2022 | 1178 | 0.130 |
Why?
|
Problem Solving | 1 | 2018 | 443 | 0.130 |
Why?
|
Nucleus Accumbens | 2 | 2010 | 365 | 0.120 |
Why?
|
Glutamine | 2 | 2009 | 574 | 0.120 |
Why?
|
Probability | 2 | 2010 | 2478 | 0.120 |
Why?
|
Anisotropy | 1 | 2018 | 1284 | 0.110 |
Why?
|
Disease Progression | 3 | 2020 | 13511 | 0.110 |
Why?
|
Outpatients | 1 | 2022 | 1598 | 0.110 |
Why?
|
Risk Factors | 11 | 2022 | 74239 | 0.110 |
Why?
|
Uncertainty | 1 | 2018 | 752 | 0.110 |
Why?
|
Skin | 2 | 2017 | 4473 | 0.110 |
Why?
|
Severity of Illness Index | 9 | 2013 | 15841 | 0.110 |
Why?
|
Periodicals as Topic | 1 | 2024 | 1463 | 0.110 |
Why?
|
Euphoria | 1 | 2013 | 65 | 0.100 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2016 | 602 | 0.100 |
Why?
|
Suicide | 2 | 2019 | 1602 | 0.100 |
Why?
|
Liver Diseases | 1 | 2021 | 1301 | 0.100 |
Why?
|
Triglycerides | 2 | 2019 | 2457 | 0.100 |
Why?
|
Basal Ganglia | 3 | 2009 | 554 | 0.100 |
Why?
|
Mothers | 1 | 2022 | 2193 | 0.100 |
Why?
|
Forecasting | 1 | 2020 | 2928 | 0.100 |
Why?
|
Anti-Inflammatory Agents | 2 | 2021 | 1812 | 0.090 |
Why?
|
Family | 2 | 2020 | 3192 | 0.090 |
Why?
|
Photic Stimulation | 2 | 2015 | 1984 | 0.090 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 4 | 2020 | 1990 | 0.090 |
Why?
|
Psychiatry | 1 | 2023 | 1699 | 0.090 |
Why?
|
Behavior Control | 1 | 2010 | 47 | 0.090 |
Why?
|
Human Development | 1 | 2010 | 123 | 0.080 |
Why?
|
Memory, Short-Term | 1 | 2016 | 982 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1803 | 0.080 |
Why?
|
Dermatitis, Atopic | 1 | 2017 | 731 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2021 | 3821 | 0.080 |
Why?
|
Psychometrics | 2 | 2015 | 3061 | 0.080 |
Why?
|
Psychotropic Drugs | 2 | 2005 | 885 | 0.070 |
Why?
|
Phosphocreatine | 1 | 2008 | 261 | 0.070 |
Why?
|
Analysis of Variance | 3 | 2010 | 6223 | 0.070 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2949 | 0.070 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5478 | 0.070 |
Why?
|
Dominance, Cerebral | 1 | 2008 | 623 | 0.070 |
Why?
|
Lithium Compounds | 1 | 2008 | 223 | 0.070 |
Why?
|
Happiness | 1 | 2007 | 170 | 0.070 |
Why?
|
Feeding Behavior | 1 | 2018 | 3183 | 0.070 |
Why?
|
Weight Gain | 1 | 2016 | 2349 | 0.070 |
Why?
|
Perceptual Disorders | 1 | 2008 | 198 | 0.060 |
Why?
|
Interleukin-6 | 1 | 2015 | 3210 | 0.060 |
Why?
|
Community Mental Health Services | 1 | 1988 | 387 | 0.060 |
Why?
|
Anger | 1 | 2007 | 405 | 0.060 |
Why?
|
Single-Blind Method | 1 | 2009 | 1577 | 0.060 |
Why?
|
Conduct Disorder | 1 | 2006 | 245 | 0.060 |
Why?
|
Evoked Potentials | 2 | 2007 | 1047 | 0.060 |
Why?
|
Double-Blind Method | 2 | 2009 | 12341 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 4340 | 0.060 |
Why?
|
Waist Circumference | 2 | 2019 | 933 | 0.060 |
Why?
|
Child of Impaired Parents | 1 | 2007 | 460 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 3089 | 0.060 |
Why?
|
Hypertension, Renovascular | 1 | 2003 | 115 | 0.050 |
Why?
|
Nonverbal Communication | 3 | 2008 | 62 | 0.050 |
Why?
|
Oxygen | 2 | 2010 | 4227 | 0.050 |
Why?
|
Pheochromocytoma | 1 | 2003 | 328 | 0.050 |
Why?
|
Infant | 2 | 2022 | 36169 | 0.050 |
Why?
|
Prevalence | 4 | 2019 | 15721 | 0.050 |
Why?
|
Linear Models | 1 | 2010 | 5869 | 0.040 |
Why?
|
Atrophy | 1 | 2005 | 1633 | 0.040 |
Why?
|
United States | 5 | 2019 | 72339 | 0.040 |
Why?
|
Autistic Disorder | 1 | 2009 | 1222 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2021 | 525 | 0.040 |
Why?
|
Sex Factors | 2 | 2020 | 10553 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15308 | 0.040 |
Why?
|
Anxiety | 2 | 2024 | 4569 | 0.040 |
Why?
|
Social Support | 1 | 1988 | 2175 | 0.040 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2003 | 732 | 0.040 |
Why?
|
Memory Disorders | 1 | 2005 | 1198 | 0.040 |
Why?
|
Demography | 2 | 2017 | 1641 | 0.040 |
Why?
|
Reaction Time | 3 | 2010 | 2087 | 0.040 |
Why?
|
Clobetasol | 1 | 2017 | 33 | 0.040 |
Why?
|
Chronic Disease | 2 | 2011 | 9319 | 0.030 |
Why?
|
Obesity | 1 | 2019 | 12939 | 0.030 |
Why?
|
Betamethasone | 1 | 2017 | 49 | 0.030 |
Why?
|
Asperger Syndrome | 1 | 2016 | 57 | 0.030 |
Why?
|
Reward | 2 | 2018 | 968 | 0.030 |
Why?
|
Incidence | 2 | 2021 | 21365 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10759 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 633 | 0.030 |
Why?
|
Behavioral Symptoms | 1 | 2017 | 186 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 2005 | 2691 | 0.030 |
Why?
|
Chorea | 1 | 1995 | 79 | 0.030 |
Why?
|
Developmental Disabilities | 2 | 2005 | 1510 | 0.030 |
Why?
|
Administration, Topical | 1 | 2017 | 703 | 0.030 |
Why?
|
Death | 1 | 2019 | 677 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2019 | 39126 | 0.030 |
Why?
|
Hyperplasia | 1 | 2017 | 1150 | 0.030 |
Why?
|
Food | 1 | 2018 | 768 | 0.030 |
Why?
|
Tacrolimus | 1 | 2017 | 736 | 0.030 |
Why?
|
Placebo Effect | 1 | 2017 | 518 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1812 | 0.030 |
Why?
|
Eosinophils | 1 | 2017 | 951 | 0.030 |
Why?
|
Hippocampus | 1 | 2005 | 3754 | 0.030 |
Why?
|
Cytokines | 2 | 2017 | 7386 | 0.020 |
Why?
|
Employment | 1 | 2018 | 1114 | 0.020 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 976 | 0.020 |
Why?
|
Wechsler Scales | 1 | 2012 | 257 | 0.020 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 130 | 0.020 |
Why?
|
Lipoproteins, HDL | 1 | 2016 | 675 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2018 | 1834 | 0.020 |
Why?
|
Needs Assessment | 1 | 2017 | 1141 | 0.020 |
Why?
|
Task Performance and Analysis | 2 | 2005 | 763 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2021 | 80674 | 0.020 |
Why?
|
Lithium | 1 | 2013 | 596 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2923 | 0.020 |
Why?
|
Brain Diseases | 1 | 1999 | 1545 | 0.020 |
Why?
|
Hospitalization | 2 | 2005 | 10707 | 0.020 |
Why?
|
Child, Preschool | 4 | 2008 | 42224 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1885 | 0.020 |
Why?
|
Risk | 1 | 2021 | 9616 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3251 | 0.020 |
Why?
|
Psoriasis | 1 | 2017 | 946 | 0.020 |
Why?
|
Washington | 1 | 1988 | 314 | 0.020 |
Why?
|
Control Groups | 1 | 2008 | 104 | 0.020 |
Why?
|
Eleutherococcus | 1 | 2007 | 5 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2008 | 284 | 0.020 |
Why?
|
Verbal Behavior | 1 | 2008 | 335 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2017 | 2726 | 0.020 |
Why?
|
Syndrome | 1 | 2013 | 3271 | 0.020 |
Why?
|
Cost Control | 1 | 1988 | 627 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2392 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2545 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3114 | 0.020 |
Why?
|
Family Health | 1 | 2010 | 1254 | 0.020 |
Why?
|
Antidepressive Agents | 2 | 2011 | 2893 | 0.020 |
Why?
|
Drugs, Chinese Herbal | 1 | 2007 | 143 | 0.020 |
Why?
|
Language Tests | 1 | 2005 | 190 | 0.020 |
Why?
|
Pilot Projects | 1 | 2018 | 8642 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 1999 | 3534 | 0.010 |
Why?
|
Testicular Hydrocele | 1 | 2003 | 27 | 0.010 |
Why?
|
Personality Assessment | 1 | 2005 | 649 | 0.010 |
Why?
|
Judgment | 1 | 2005 | 272 | 0.010 |
Why?
|
Psychosomatic Medicine | 1 | 2003 | 72 | 0.010 |
Why?
|
Aggression | 1 | 2007 | 748 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9416 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2005 | 1240 | 0.010 |
Why?
|
Animals | 3 | 2024 | 168079 | 0.010 |
Why?
|
Recurrence | 1 | 2013 | 8457 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2017 | 10203 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2005 | 3418 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11509 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29893 | 0.010 |
Why?
|
Visual Cortex | 1 | 2007 | 1104 | 0.010 |
Why?
|
Aged | 3 | 2019 | 169288 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4246 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 24021 | 0.010 |
Why?
|
Middle Aged | 3 | 2019 | 220853 | 0.010 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 1999 | 509 | 0.010 |
Why?
|
Discriminant Analysis | 1 | 1996 | 224 | 0.010 |
Why?
|
Tomography, Emission-Computed | 1 | 1999 | 1123 | 0.010 |
Why?
|
Intelligence Tests | 1 | 1996 | 503 | 0.010 |
Why?
|
Globus Pallidus | 1 | 1996 | 250 | 0.010 |
Why?
|
Magnetoencephalography | 1 | 1999 | 636 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2770 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1999 | 1130 | 0.010 |
Why?
|
Cerebral Ventricles | 1 | 1996 | 542 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12052 | 0.010 |
Why?
|
Body Height | 1 | 1996 | 1566 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41496 | 0.010 |
Why?
|
Schizophrenia | 1 | 1988 | 6930 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2683 | 0.010 |
Why?
|
Cerebellum | 1 | 1996 | 1501 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2013 | 64681 | 0.000 |
Why?
|
Body Weight | 1 | 1996 | 4618 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 1988 | 58952 | 0.000 |
Why?
|
Infant, Newborn | 1 | 1999 | 26199 | 0.000 |
Why?
|